Aristotle Introduces Integrity FinAfford and Partnership With Department of Trust for Financial Risk Checks
WASHINGTON, D.C., WASHINGTON, D.C. / ACCESS Newswire / January 16, 2025 / Aristotle Integrity, the KYC and Identity division of Aristotle, is delighted to announce its partnership with the Department of Trust to deliver affordability checks and advanced diligence technology. This partnership addresses the needs of UK-regulated online gambling companies, which must comply with stricter UKGC responsible gambling requirements effective from 28th February 2025. From this date, online gambling operators are required to perform financial risk checks when a player's net deposits exceed £150 within a 30-day period - approximately 20% of online players. Additional due diligence is also mandated for higher spending or identified risks that warrant intervention.
John Aristotle Phillips, CEO of Aristotle, commented:
"The ability to integrate such a valuable technology like the Department of Trust's will further enhance our Integrity FinAfford™ product. By combining Aristotle's extensive history and performance in the regulated iGaming business for KYC with the Department of Trust's award-winning financial risk and vulnerability checks into a unified service, FinAfford provides an ideal solution for operators needing a seamless way to integrate and meet the rapidly approaching compliance deadline and beyond."
DoTrust CEO Charles Cohen added:
"We are thrilled to have been selected by Aristotle to enhance FinAfford™ with our comprehensive range of risk assessments. Aristotle holds a leading position in the global iGaming market and enjoys a strong reputation for customer focus and innovation. Through this partnership, we will deliver our uniquely compliant, accurate, and auditable risk assessments to more operators at this critical juncture."
Integrity FinAfford™, when combined with Aristotle's Integrity IDV product within the KYC process, simplifies player onboarding. FinAfford™ enables operators to conduct financial risk checks simultaneously, providing assessments and other key variables to operators, helping them determine deposit thresholds per player and reduce exposure to social responsibility challenges in the future. UK iGaming operators now have access to a combined product that facilitates setting initial player deposit limits and, as the player's activity increases, seamlessly meets higher diligence requirements.
Aristotle plans to extend its Integrity FinAfford™ product to Brazil, anticipating similar responsible iGaming affordability checks in this newly regulated market. Phillips added:
"Integrity has always been at the forefront of regulated iGaming markets, and supporting our partners in meeting their regulatory obligations is central to our technological development. As iGaming markets mature, regulatory bodies assess the political and social landscapes and adapt their requirements. We anticipate responsible gaming provisions becoming an integral part of regulations, and FinAfford™ is designed to help our partners meet these needs. In addition to Brazil, we are exploring the expansion of Integrity FinAfford's coverage to the United States."
About Aristotle Integrity Aristotle Integrity is a leader in identity and KYC solutions for regulated markets, providing innovative tools to ensure compliance and streamline operations. For more information, visit integrity.aristotle.com
About Department of Trust The Department of Trust is an award-winning provider of financial risk and vulnerability checks, offering cutting-edge solutions for responsible gaming and compliance. Learn more at dotrust.co.uk
Media Contact: Brandi Travis
CMO, Aristotle
press@aristotle.com
###
Contact Information
Brandi Travis
CMO
brandi.travis@aristotle.com
270-704-2462
SOURCE: Aristotle
View the original press release on ACCESS Newswire
Aristotle
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 202527.10.2025 14:00:00 CET | Press release
With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents - manufactured to the highest quality standards for faster, more efficient API development. TEWKSBURY, MASSACHUSETTS / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), a global leader in stable isotope chemistry, announces the launch of ISOAPI-D™, a unified brand of deuterated intermediates for API synthesis. The new ISOAPI-D brand will be launched at CPhI Frankfurt, where CIL welcomes industry professionals to stand #2.0G2 from October 28-30.ISOAPI-D ISOAPI-D Power of Deuterium: Smarter, Stronger Therapeutics "ISOAPI-D reagents are designed to support the development of next-generation active pharmaceutical ingredients (APIs) by leveraging the unique benefits of deuterium incorporation," said Cliff Caldwell, CEO of CIL. "With ISOAPI-D, our customers gain access to a trusted and secure supply chain, ensuring they have consistent, reliable access to the materi
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India27.10.2025 13:45:00 CET | Press release
Strategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad's Genome Valley, Enhancing Global Production and Supply of Isotopically Enriched Chemical Solutions for Pharmaceutical and Electronics Industries TEWKSBURY, MA AND HYDERABAD, INDIA / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), and Chemtatva Chiral Solutions, Pvt. Ltd. (CCS), a leading provider of chiral and specialty chemical solutions, announce the execution of a signed Memorandum of Understanding to establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India. This initiative marks a milestone in the expansion of CIL's global footprint and further enhances capabilities in the development and production of deuterated reagents and other isotopically enriched products. This partnership will enhance global supply chain strength and real-time support for customers in Asia and enable multi-site production for global customers focused on business continui
Sauce Labs and Deque Systems Partner to Deliver Comprehensive Accessibility Testing at Scale24.10.2025 07:00:00 CEST | Press release
SAN FRANCISCO, CA / ACCESS Newswire / October 24, 2025 / Sauce Labs Inc., a leading provider of continuous testing solutions, and Deque Systems, Inc., a trusted leader in digital accessibility, today announced a strategic partnership to help companies ensure compliance with accessibility regulations and deliver accessible digital experiences across all devices and platforms. The collaboration combines Sauce Labs' extensive real-device coverage and scalable cloud infrastructure with Deque's unparalleled accessibility expertise. This partnership is a renewed commitment, building on a long-standing relationship between the two companies. By doubling down on their joint offering, Sauce Labs and Deque are providing a comprehensive solution for accessibility testing at scale. The partnership addresses the growing need for businesses to meet digital accessibility standards, especially with the upcoming European Accessibility Act (EAA), which became law on June 28, 2025. The EAA requires produ
Florence Connects 65,000+ Study Sites and 600+ Sponsors Worldwide - Unleashing the Next Era of Clinical Trial Intelligence23.10.2025 14:00:00 CEST | Press release
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational risk management. ATLANTA, GA / ACCESS Newswire / October 23, 2025 / Florence Healthcare reinforced its position as the global leader in clinical trial operations with a major milestone: Florence Trial Operations Platform now connects 65,000 study sites spanning more than 600 sponsors across 90+ countries, forming the industry's largest network. Recognized as the #1 clinical trial technology for six consecutive years, Florence continues to set the standard for startup speed, workflow automation, and operational risk management across sponsor study portfolios. "Florence was built to bring sponsors and sites into a shared operational space," said Ryan Jones, CEO of Florence Healthcare. "First, we fully digitized startup to eliminate manual bottlenecks and paper workflows. Now, we're using AI to enhance speed and augment intelligence across 65,000 s
U.S. Polo Assn. Wins Gold and Silver Stevie Awards at the 2025 International Business Awards in Lisbon, Portugal23.10.2025 13:00:00 CEST | Press release
LISBON, PT AND WEST PALM BEACH, FL / ACCESS Newswire / October 23, 2025 / USPA Global today announced that U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), has been awarded two prestigious Stevie® Awards from the 22nd Annual International Business Awards® (IBA).U.S. Polo Assn. Wins Two Stevie® Awards U.S. Polo Assn. was celebrated during an elegant gala event at the Corinthia Hotel in Lisbon, Portugal, on Friday, October 10, attended by leadership from USPA Global and the brand's strategic partners in the region. The global event hosted over 350 guests from more than 30 nations, including many of the world's top companies and Stevie winners, including Coca-Cola, Starbucks, Lenovo, Kendra Scott, IBM, and Turkish Airlines. The brand's winning entries included a Gold Stevie Award for 'Achievement in International Expansion' and a Silver Stevie Award in 'Celebration Event' for the 2024 Paris Games Polo Challenge campaign. The multi-billion-dollar, sp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom